nafamostat and edetic acid

nafamostat has been researched along with edetic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Inoue, M; Kato, H; Kondo, M; Sano, H; Sugino, S; Tanigawa, M; Yamamura, Y1
Akihama, S; Matsuda, Y; Oshio, S; Umeda, T; Yazaki, T1
Andoh, A; Bamba, T; Fujiyama, Y; Kimura, T; Saotome, T1
Hugli, TE; Kawahara, MS; Pfeifer, PH1
Fujimoto, S; Fujita, H; Hazama, Y; Kuhara, K; Moriyama, A; Nishimura, S; Ohtake, C; Sakuma, R1
Alix, M; Boehm, T; Borth, N; Gludovacz, E; Jilma, B; Petroczi, K; Salminen, TA; Vakal, S1

Other Studies

6 other study(ies) available for nafamostat and edetic acid

ArticleYear
Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
    Natural immunity and cell growth regulation, 1989, Volume: 8, Issue:5

    Topics: Animals; Arachidonic Acids; Benzamidines; Benzoquinones; Biological Products; Cell Count; Chemotactic Factors; Complement C5a; Complement Inactivator Proteins; Edetic Acid; Egtazic Acid; Guanidines; Humans; Male; Methacrylates; Neutrophils; Peritoneal Cavity; Picibanil; Quinones; Rats; Rats, Inbred Strains; Sesquiterpenes

1989
The effect of some proteinase inhibitors on liquefaction of human semen.
    Human reproduction (Oxford, England), 1994, Volume: 9, Issue:4

    Topics: Adult; Benzamidines; Edetic Acid; Glycopeptides; Glycoproteins; Guanidines; Humans; Male; Oligopeptides; Plant Proteins; Protease Inhibitors; Semen; Sperm Motility

1994
A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.
    Clinical and experimental immunology, 1998, Volume: 111, Issue:3

    Topics: Anaphylatoxins; Animals; Benzamidines; Cell Degranulation; Cell Membrane Permeability; Chelating Agents; Chromium Radioisotopes; Complement Activation; Complement Inactivator Proteins; Edetic Acid; Guanidines; Intestinal Mucosa; Ischemia; Jejunum; Male; Mast Cells; Rats; Rats, Wistar; Reperfusion Injury; Serine Proteinase Inhibitors; Sesquiterpenes

1998
Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation.
    Clinical chemistry, 1999, Volume: 45, Issue:8 Pt 1

    Topics: Adult; Anticoagulants; Benzamidines; Blood Specimen Collection; Complement C3a; Complement C4a; Edetic Acid; Female; Guanidines; Humans; Liver Transplantation; Male; Middle Aged; Radioimmunoassay

1999
Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
    Transfusion medicine (Oxford, England), 2012, Volume: 22, Issue:3

    Topics: Anticoagulants; Benzamidines; Calcium; Citrates; Citric Acid; Drug Evaluation, Preclinical; Edetic Acid; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Gabexate; Glucose; Guanidines; Hemoglobins; Hemolysis; Humans; In Vitro Techniques; Infusion Pumps; Infusions, Intravenous; L-Lactate Dehydrogenase; Membrane Lipids; Phosphatidylserines; Solutions

2012
Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration.
    The Journal of pharmacology and experimental therapeutics, 2022, Volume: 382, Issue:2

    Topics: Amine Oxidase (Copper-Containing); Anaphylaxis; Benzamidines; Diminazene; Edetic Acid; Guanidines; Histamine; Humans

2022